The presentation of viral hepatitis C infection without cryoglobulinemia with a peripheral neuropathy. Five case reports;Neuropathies périphériques sans cryoglobulinémie révélatrices de l'hépatite virale C. À propos de cinq observations

Revue Neurologique

Volumn 162, Issue 5, 2006, Pages 623-627

  Rafai, M A ^a,c   Gam, I ^a   Fadel, H ^a   Hakim, K ^a   El Moutawakkil, B ^a   Bendahmane, A ^b   Kissani, N ^d   Alaoui, R ^b   Cherkaoui, A ^b   Slassi, I ^a  

^a Service de Neurologie Explorations Fonctionnelles   (Morocco)

^b IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

^c Laboratoire de microbiologie   (Morocco)

^d NONE

Author keywords

Cryoglobulinemia; Peripheral neuropathies; Viral hepatitis C infection

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; PREDNISOLONE; RIBAVIRIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CRYOGLOBULINEMIA; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; PERIPHERAL NEUROPATHY; VIRUS HEPATITIS;

EID: 33646750549     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(06)75056-1     Document Type: Article

References (27)

1. ANDRES E, GOICHOT B, IMLER M, SCHLIENGER JL et al. (1999). Virus de l'hépatite c et atteinte neurologique périphérique : rôle des anticorps antigangliosides. Gastroenterol Clin Biol, 23 : 688.
2. APARTIS E, LEGER JM, MUSSET L et al. (1996). Peripheral neuropathy associated with essential mixed cryoglobulinaemia: a role for hepatitis C virus infection? J Neurol Neurosurg Psychiatry, 60: 661-666.
3. AUTHIER FJ, BASSEZ G, PAYAN C et al. (2003). Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy. Neurology, 60: 808-812.
4. BONETTI B, SCARDONI M, MONACO S et al. (1999). Hepatitis C virus infection of peripheral nerve in type II cryoglobulinaemia. Virchows Arch, 434: 533-535.
5. CACOUB P. (1998). Virus de l'hépatite C et atteintes neurologiques. Gastroenterol Clin Biol, 22 : 889-890.
6. CACOUB P, SBAI M, WECHSLER B et al. (1999). Polyradiculonévrite inflammatoire chronique et virus de l'hépatite C. Rev Med Interne, 20 : 1146-1151.
7. CACOUB P, MAISONOBE T, THIBAUL T et al. (2001). Systemic vasculitis in patient with hepatitis C. J Rheumatol, 28: 109-118.
8. CACOUB P, LIDOVE O, MAISONOBE T et al. (2002). Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum, 46: 3317-3326.
9. DE MARTINO L, SAMPAOLO S, TUCCI C et al. (2003). Viral RNA in nerve tissues of patients with hepatitis C infection and peripheral neuropathy. Muscle Nerve, 27: 102-104.
10. FERRI C, MARZO E, LONGOMBARDO G et al. (1993). Interferon alpha in mixed cryoglobulinmia patient: rndomized, crossover-controlled trial. Blood, 81: 1132-1136.
11. GARCIA-BRAGADO F, FERNANDEZ JM, NAVARRO C et al. (1998). Peripheral neuropathy in essential mixed cryoglobulinaemia. Arch Neurol, 45: 1210-1214.
12. GHIJSELS E, LERUT E, VANRENTERGHEM Y et al. (2004). Anti-CD20 monoclonal antibody (rituximab) treatment for hepatitis C-negative therapy-resistant essential mixed cryoglobulinemia with renal and cardiac failure. Am J Kidney Dis, 43: e34-e38.
13. HECKMANN JG, KAYSER C, HEUSS D et al. (1999). Neurological manifestations of chronic hepatitis C. J Neurol, 246: 486-491.
14. IJITCHI T, KONO I, MORI S et al. (2003). Peripheral neuropathy in Japanese patients with hepatitis C virus infection. Internal Medicine, 42: 394-399.
15. JORGENSEN C, LEGOUFFE MC, PERNEY P et al. (1996). Sicca syndrome associated with hepatitis C virus infection. Arthritis and Rheumatism, 39: 1166-1171.
16. KANDA T. (2003). Chronic hepatitis C infection and peripheral neuropathy; is mixed cryoglobulinaemia really important? Internal Medicine, 42: 377-378.
17. LAMPRECHT P, LERIN-LOZANO C, MERZ H et al. (2003) Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis. Ann Rheum Dis, 62: 1230-1233.
18. LIDOVE O, MAISONOBE T, SERVAN J et al. (2001a). Neuropathie périphérique et infection par le virus de l'hépatite C : ne pas s'arrêter à la cryoglobulinémie. Rev Med Interne, 22 : 939-947.
19. LIDOVE O, CACOUB P, MAISONOBE T et al. (2001b). Hepatitis C virus infection with peripheral neuropathy is not always associated with cryoglobulinaemia. Ann Rheum Dis, 60: 290-292.
20. LUNNEL F, MUSSET L, CACOUB P et al (1994). Cryoglobulinemia in chronic liver disease: role of hepatitis C virus and liver damage. Gastroenterology, 106: 1291-1300.
21. MAISONOBE T, LEGER JM, MUSSET L, CACOUB P. (2002). Manifestations neurologiques des cryoglobulinemies. Rev Neurol (Paris), 158 : 920-924.
22. MCKEE DH, YOUNG AC, DOMINGUEZ A et al. (2000). Neurologic complications associated with hepatitis C virus infection. Neurology, 55 : 459.
23. NEMNI R, SANVITO L, QUATTRINI A et al. (2003). Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia. J Neurol Neurosurg Psychiatry, 74: 1267-1271.
24. PAOELETTI V, DONNARUMMA L, DE MATTEIS A et al. (2000). Peripheral neuropathy without cryoglobulinaemia in patients with hepatitis C virus infection. Panminrva Med, 42: 175-178.
25. POYNARD T, BEDOSSA P, OPOLON P. (1997). Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet, 349: 825-832.
26. TEMBL JI, FERRER JM, SEVILLA MT et al. (1999). Neurologic complications associated with hepatitis C virus infection. Neurology, 53: 861.
27. WEITZ IC. (2005). Treatment of immune thrombocytopenia associated with interferon therapy of hepatitis C with the anti-CD20 monoclonal antibody, rituximab. Am J Hematol, 78: 138-141.